Sander Ellegård
Publikationer
2026
Grand SLAM study protocol: a prospective randomised multicentre study of shortened versus standard duration adjuvant immune checkpoint inhibition for stage IIB-C, III and IV cutaneous melanoma
BMC Cancer, Vol. 26, Artikel 460
(Artikel i tidskrift)
https://dx.doi.org/10.1186/s12885-026-15924-4
2024
HER2-positive breast cancer: Clinical and molecular aspects
(Doktorsavhandling, sammanläggning)
https://dx.doi.org/10.3384/9789180756242
2022
Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study
Frontiers in Oncology, Vol. 12, Artikel 861324
(Artikel i tidskrift)
https://dx.doi.org/10.3389/fonc.2022.861324
2019
ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab
Oncology Letters, Vol. 17, s. 3371-3381
(Artikel i tidskrift)
https://dx.doi.org/10.3892/ol.2019.9998
2013
The Role of MicroRNA-200 in Progression of Human Colorectal and Breast Cancer
PLOS ONE, Vol. 8, s. 84815-
(Artikel i tidskrift)
https://dx.doi.org/10.1371/journal.pone.0084815